TNSN05047A1 - Inhalation composition - Google Patents
Inhalation compositionInfo
- Publication number
- TNSN05047A1 TNSN05047A1 TNP2005000047A TNSN05047A TNSN05047A1 TN SN05047 A1 TNSN05047 A1 TN SN05047A1 TN P2005000047 A TNP2005000047 A TN P2005000047A TN SN05047 A TNSN05047 A TN SN05047A TN SN05047 A1 TNSN05047 A1 TN SN05047A1
- Authority
- TN
- Tunisia
- Prior art keywords
- microns
- particles
- diameter
- less
- inhalation composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Otolaryngology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention provides a dry powder inhalation composition comprising medicament particles and a mixture of laclose particles with a VMD of between about 70 and about 120 microns and a diameter of less than 250 microns, the mixture being characterized in that up to 96% by weight of the lactose particles are less than 150 microns in diameter and wherein up to 25% by weight of the lactose particles are less than 5 microns in diameter. The compositions provide for a more accurate, uniform and consistent dispersion when used with, for example, a multidose dry powder inhaler. Also disclosed are methods for use of the compositions of the invention.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0219513A GB0219513D0 (en) | 2002-08-21 | 2002-08-21 | Inhalation compositions including coarse carrier |
PCT/US2003/026385 WO2004017914A2 (en) | 2002-08-21 | 2003-08-21 | Inhalation composition |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN05047A1 true TNSN05047A1 (en) | 2007-05-14 |
Family
ID=9942746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2005000047A TNSN05047A1 (en) | 2002-08-21 | 2005-02-18 | Inhalation composition |
Country Status (8)
Country | Link |
---|---|
BR (1) | BRPI0313647A2 (en) |
CA (1) | CA2499273C (en) |
ES (1) | ES2371601T3 (en) |
GB (1) | GB0219513D0 (en) |
NO (1) | NO20051461L (en) |
TN (1) | TNSN05047A1 (en) |
WO (1) | WO2004017914A2 (en) |
ZA (1) | ZA200502177B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007533387A (en) | 2004-04-21 | 2007-11-22 | イノベータ バイオメド リミテッド | Inhaler |
BRPI0510119A (en) | 2004-04-23 | 2007-09-25 | Cydex Inc | formulation for dpi containing sulfoaquil cyclodextrin ether |
GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
WO2006086270A1 (en) | 2005-02-10 | 2006-08-17 | Glaxo Group Limited | Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom |
US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
GB0605723D0 (en) * | 2006-03-23 | 2006-05-03 | 3M Innovative Properties Co | Powder filling processes |
WO2008134817A1 (en) * | 2007-05-03 | 2008-11-13 | The University Of Sydney | Composite carriers for dry powder inhalation therapy |
TR201205852A2 (en) * | 2011-06-02 | 2012-12-21 | Bi̇lgi̇ç Mahmut | Improved new dry powder formulation. |
TR201105367A2 (en) * | 2011-06-02 | 2012-12-21 | Bi̇lgi̇ç Mahmut | A dry powder formulation with improved flow properties. |
US20150150802A1 (en) | 2012-07-05 | 2015-06-04 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhaler compositions comprising long acting muscarinic antagonists |
AU2013290616B2 (en) | 2012-07-19 | 2016-03-10 | Adamis Pharmaceuticals Corporation | Powder feeding apparatus |
JP6251667B2 (en) | 2014-06-03 | 2017-12-20 | アサヒカルピスウェルネス株式会社 | Tablet-type immediate release preparation and method for producing the same |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU226164B1 (en) * | 1998-11-13 | 2008-05-28 | Jagotec Ag | Use of magnesium stearate in dry powder compositions suitable for inhalation and compositions suitable for inhalation |
AU1786199A (en) * | 1998-12-11 | 2000-07-03 | Pharmachemie B.V. | Pharmaceutical preparation for inhalation of an opioid |
UA75375C2 (en) | 2000-10-12 | 2006-04-17 | Boehringer Ingelheim Pharma | Method for producing powdery preparations for inhaling |
HU226982B1 (en) | 2000-10-12 | 2010-04-28 | Boehringer Ingelheim Pharma | Novel tiotropium-containing inhalation powder, process for its preperation and its use |
-
2002
- 2002-08-21 GB GB0219513A patent/GB0219513D0/en not_active Ceased
-
2003
- 2003-08-21 WO PCT/US2003/026385 patent/WO2004017914A2/en active Application Filing
- 2003-08-21 CA CA2499273A patent/CA2499273C/en not_active Expired - Fee Related
- 2003-08-21 ES ES03751884T patent/ES2371601T3/en not_active Expired - Lifetime
- 2003-08-21 BR BRPI0313647A patent/BRPI0313647A2/en active Search and Examination
-
2005
- 2005-02-18 TN TNP2005000047A patent/TNSN05047A1/en unknown
- 2005-03-15 ZA ZA200502177A patent/ZA200502177B/en unknown
- 2005-03-18 NO NO20051461A patent/NO20051461L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
GB0219513D0 (en) | 2002-10-02 |
WO2004017914A8 (en) | 2005-07-07 |
ZA200502177B (en) | 2006-05-31 |
CA2499273A1 (en) | 2004-03-04 |
CA2499273C (en) | 2011-06-21 |
WO2004017914A2 (en) | 2004-03-04 |
ES2371601T3 (en) | 2012-01-05 |
WO2004017914A3 (en) | 2004-04-29 |
NO20051461L (en) | 2005-05-20 |
BRPI0313647A2 (en) | 2019-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN05047A1 (en) | Inhalation composition | |
MXPA02012023A (en) | Highly efficient delivery of a large therapeutic mass aerosol. | |
EP1599209A4 (en) | Inhalation composition | |
AU2001293899A1 (en) | Ihnalation particles incorporating a combination of two or more active ingredients | |
ATE271383T1 (en) | POWDER FORMULATION FOR INHALATION | |
GB0425758D0 (en) | Preparation of pharmaceutical compositions | |
JO2430B1 (en) | Pharmaceuticall Formulations for Dry Powder Inhalers in the form of Hard- Pellets | |
WO2005079755A3 (en) | Interleukin-13 antagonist powders, spray-dried particles, and methods | |
HUP0300499A2 (en) | Pharmaceutical formulations for dry powder inhalers | |
MX9700034A (en) | Inhalation composition. | |
TW200505483A (en) | New medicament compositions based on anticholinergically-effective compounds and β-mimetics | |
WO2002043700A3 (en) | Particles for use in a pharmaceutical composition | |
WO2004017918A8 (en) | Method of preparing dry powder inhalation compositions | |
AU2002357457A1 (en) | Powder for nasal administration of drugs | |
ZA202201322B (en) | Pharmaceutical composition comprising ensifentrine | |
FI20002216A0 (en) | Combination particles for asthma therapy | |
TW200730170A (en) | Micronised azodicarbonamide, and the preparation and use thereof | |
EA200500387A1 (en) | COMPOSITIONS FOR INHALATION WITH HIGH CONTENT OF MEDICINAL SUBSTANCES | |
EA200900464A1 (en) | PHARMACEUTICAL COMPOSITION FOR INHALATION | |
MY140890A (en) | New tiotropium containing powder formulation for inhalation | |
AU2002314972A1 (en) | Compressible guaifenesin compositions and method for producing them | |
PL365736A1 (en) | Bimodal dry powder formulation for inhalation | |
NZ509881A (en) | Micronised pharmaceutical compositions containing colistin sulphomethate sodium |